Lucy Megumi Yamauchi

ORCID: 0000-0003-2241-8814
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Trypanosoma species research and implications
  • Research on Leishmaniasis Studies
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial biofilms and quorum sensing
  • Synthesis and Biological Evaluation
  • Antifungal resistance and susceptibility
  • Bacterial Identification and Susceptibility Testing
  • Neonatal and Maternal Infections
  • Fungal Infections and Studies
  • Antibiotic Resistance in Bacteria
  • Streptococcal Infections and Treatments
  • Antimicrobial Peptides and Activities
  • Nail Diseases and Treatments
  • Toxin Mechanisms and Immunotoxins
  • Insect Pest Control Strategies
  • Parasites and Host Interactions
  • Maternal and Neonatal Healthcare
  • Helminth infection and control
  • Essential Oils and Antimicrobial Activity
  • SARS-CoV-2 and COVID-19 Research
  • Bee Products Chemical Analysis
  • Toxoplasma gondii Research Studies
  • Global Maternal and Child Health
  • Calcium signaling and nucleotide metabolism
  • Healthcare during COVID-19 Pandemic

Universidade Estadual de Londrina
2016-2025

Universidade Estadual do Norte do Paraná
2021

New York University
2007

Clinics Hospital of Ribeirão Preto
2006

Universidade Federal de São Paulo
1996-2000

Plasmodium sporozoites make a remarkable journey from the skin, where they are deposited by an infected Anopheline mosquito, to liver, invade hepatocytes and develop into exoerythrocytic stages. Although much work has been done elucidate molecular mechanisms which hepatocytes, little is known about interactions between host parasite before sporozoite enters blood circulation. It always assumed that rapidly exit injection site, making their with at this brief difficult study. Using...

10.1111/j.1462-5822.2006.00861.x article EN Cellular Microbiology 2007-01-11

The 43,000-Da glycoprotein (gp43) of Paracoccidioides brasiliensis is an immunodominant antigen for antibody-dependent and immune cellular responses in patients with paracoccidioidomycosis. In order to identify the peptide epitopes involved immunological reactivities gp43 obtain highly specific recombinant molecules diagnosis infection, genomic cDNA clones representing entire coding region were sequenced. open reading frame was found a 1,329-base pair fragment 2 exons interrupted by intron...

10.1074/jbc.271.8.4553 article EN cc-by Journal of Biological Chemistry 1996-02-01

Silver nanoparticles (AgNPs) have been extensively studied because of their anti-microbial potential. Here, we evaluated the effect biologically synthesized silver (AgNP bio ) alone and in combination with fluconazole (FLC) against planktonic cells biofilms FLC-resistant Candida albicans . AgNP exhibited a fungicidal effect, minimal inhibitory concentration (MIC) ranging from 2.17 to 4.35 μg/ml. The FLC reduced MIC around 16 64 times all C. There was no significant on biofilm cells. However,...

10.1093/mmy/myv036 article EN Medical Mycology 2015-06-19

American cutaneous leishmaniasis is a zoonotic disease caused by protozoans of the genus Leishmania. The treatment unsatisfactory, thus, much research effort has been focused on investigating new compounds with lower collateral effects to patients and derived from low-cost sources, such as natural products. In present study, we evaluated in vitro directly effect flavonoid quercetin against Leishmania (Viannia) braziliensis. Quercetin inhibited proliferation promastigote forms at all tested...

10.1016/j.biopha.2019.108745 article EN cc-by-nc-nd Biomedicine & Pharmacotherapy 2019-03-02

Leukotrienes are important mediators of inflammatory responses. In this study, we investigated the effect absence 5-lipoxygenase (5-LO)-derived leukotrienes on levels cytokines, nitric oxide (NO) and iNOS expression in cardiac tissue mice infected with Trypanosoma cruzi, agent Chagas' disease. NO is a key mediator parasite killing experimentally T. previous studies have suggested that leukotrienes, such as LTB(4), induces synthesis cruzi-infected macrophages plays relevant role NO-dependent...

10.1016/j.exppara.2010.06.030 article EN publisher-specific-oa Experimental Parasitology 2010-07-02

Most Candida spp. infections are associated with biofilm formation on host surfaces. Cells within these communities display a phenotype resistant to antimicrobials and defenses, so biofilm-associated difficult treat, representing source of reinfections. The present study evaluated the effect eugenol adherence properties capacity dubliniensis tropicalis isolated from oral cavity HIV-infected patients. All isolates were able form biofilms different substrate Eugenol showed inhibitory activity...

10.1155/2014/505204 article EN cc-by Evidence-based Complementary and Alternative Medicine 2014-01-01

Streptococcus agalactiae or Group B Streptococci (GBS) have the ability to access various host sites, which reflects its adaptability different environments during course of infection. This adaptation is due expression virulence factors that are involved with survival, invasion and bacterial persistence in host. study aimed characterize GBS isolates from women reproductive age seen at University Hospital Londrina, according capsular typing, genetic relatedness, antimicrobial susceptibility...

10.1186/1471-2180-13-297 article EN cc-by BMC Microbiology 2013-12-01

Streptococcus agalactiae (group B streptococci (GBS)) is an important infections agent in newborns associated with maternal vaginal colonization. Intrapartum antibiotic prophylaxis GBS-colonized pregnant women has led to a significant reduction the incidence of early neonatal infection various geographic regions. However, this strategy may lead resistance selecting among GBS, indicating need for new alternatives prevent bacterial transmission and even treat GBS infections. This study...

10.1155/2015/861497 article EN Evidence-based Complementary and Alternative Medicine 2015-01-01

Candida species are some of the most common causes fungal infection worldwide. The limited efficacy clinically available antifungals warrants search for new compounds treating candidiasis. This study evaluated effect condensed tannin-rich fraction (F2 fraction) Stryphnodendron adstringens on in vitro and vivo growth tropicalis, yeast adhesion properties. F2 exhibited a fungistatic with minimum inhibitory concentration ranging from 0.5 to 8.0 μg/mL. A significant reduction biofilm mass was...

10.2174/1389201017666151223123712 article EN Current Pharmaceutical Biotechnology 2016-02-15

The increase in multidrug-resistant microorganisms represents a global threat requiring the development novel strategies to fight bacterial infection. This study aimed assess effect of silver nanoparticles (bio-AgNPs) on growth, biofilm formation, production virulence factors, and expression genes related quorum-sensing (QS) system P. aeruginosa PAO1 PA14. Biofilm formation assays were performed with bio-AgNPs. RT-qPCR was carried out determine bio-AgNPs QS regulatory lasI, lasR, rhlI, rhlR,...

10.3390/microorganisms10091755 article EN cc-by Microorganisms 2022-08-30

Since ancient times, plants have been used in folk medicine to treat different diseases. Plants offer exceptional chemical diversity with a wide range of biological activities, and therefore the most promising sources for discovery development drugs, including antimicrobial agents. This study reports antibacterial effect geraniol (GER), alone combination biogenic silver nanoparticles (bioAgNPs), produced using aqueous extract Trichilia catigua bark, against planktonic sessile cells...

10.3390/plants14071059 article EN cc-by Plants 2025-03-29

The fact that drugs currently used in the treatment of Leishmania are highly toxic and associated with acquired resistance has promoted search for new therapies treating American tegumentary leishmaniasis (ATL). In this study, BALB/c mice were injected hind paw (Leishmania) amazonensis subsequently treated a combination nitric oxide (NO) donor (cis-[Ru(bpy) 2imN(NO)](PF6)3) (Ru-NO), given by intraperitoneal injection, oral Brazilian propolis 30 days. Ru-NO reached center lesion increased NO...

10.1371/journal.pone.0125101 article EN cc-by PLoS ONE 2015-05-14

Abstract Background To overcome the problem of increasing drug resistance, traditional medicines are an important source for potential new anti-malarials. Caesalpinia pluviosa , commonly named "sibipiruna", originates from Brazil and possess multiple therapeutic properties, including anti-malarial activity. Methods Crude extract (CE) was obtained stem bark by purification using different solvents, resulting in seven fractions. An MTT assay performed to evaluate cytotoxicity MCF-7 cells. The...

10.1186/1475-2875-10-112 article EN cc-by Malaria Journal 2011-05-02

ABSTRACT American trypanosomiasis, or Chagas' disease, is caused by Trypanosoma cruzi and affects around 15 million people throughout the continent. The available treatment based on two nitroheterocyclic drugs, nifurtimox benznidazole, both only partially effective toxic. In this context, new drugs must be found. our previous work, tetrahydro-β-carboline compound N -butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide, named C4, showed a potent in vitro trypanocidal...

10.1128/aac.05575-11 article EN Antimicrobial Agents and Chemotherapy 2011-10-29

Introduction: Host colonization by Candida species is an important predisposing factor to candidiasis, which seems be more frequent in human immunodeficiency virus (HIV)-infected patients. Knowledge about the distribution, antifungal susceptibility, and virulence of oral isolates for effective management candidiasis. Methodology: Oral rinses were collected from 242 HIV-infected patients without clinical evidence candidiasis seen at AIDS referral center Londrina, Brazil. Species identified...

10.3855/jidc.6970 article EN cc-by The Journal of Infection in Developing Countries 2015-12-30

This study aimed to characterize the main mechanisms of acquired antimicrobial resistance 103 multidrug-resistant Acinetobacter baumannii isolated from bloodstream 2006 2016 a hospital in Londrina, Brazil. All isolates were identified as A. by amplification blaOXA-51-like and rpoB genes. Mortality was observed majority (81.6%) patients. High non-susceptibility rates (100.0-10.7%) obtained for evaluated antimicrobials, including colistin, polymyxin B, tigecycline, most classified extensively...

10.1089/mdr.2019.0002 article EN Microbial Drug Resistance 2019-07-30

Background. Staphylococcus aureus can asymptomatically colonize the human anterior nares and skin, nasal colonization by this bacterium represents a potential risk for development of invasive infections. The aim study was to determine prevalence S. carriage among healthcare workers students attending university hospital characterize isolates phenotypically molecularly. Methods. A cross-sectional performed with 324 volunteers. Cultures from samples were obtained characterized according their...

10.1155/2020/3808036 article EN cc-by Interdisciplinary Perspectives on Infectious Diseases 2020-12-03

Candida auris has been found to be a persistent colonizer of human skin and successful pathogen capable causing potentially fatal infection, especially in immunocompromised individuals. This fungal species is usually resistant most antifungal agents the ability form biofilms on different surfaces, representing significant therapeutic challenge. Herein, effect metabolites Pseudomonas aeruginosa LV strain, alone combined with biologically synthesized silver nanoparticles (bioAgNP), was...

10.3390/antibiotics12050861 article EN cc-by Antibiotics 2023-05-06

Multidrug-resistant organisms (MDRO) are a great problem in hospitals, where thousands of people infected daily, with the occurrence high mortality rates, especially infections caused by Klebsiella pneumoniae carbapenemase-producing K. (KPC-producing Kpn). The challenge is to find new compounds that can control KPC producing-Kpn infections. aim this study was evaluate antibiotic activity F3d fraction produced Pseudomonas aeruginosa LV strain against clinical isolates KPC-producing Kpn....

10.2174/138920101704160215171649 article EN Current Pharmaceutical Biotechnology 2016-02-15
Coming Soon ...